Spasmus nutans

Definition

Spasmus nutans is a disorder affecting infants and young children. It involves rapid, uncontrolled eye movements, head bobbing, and sometimes, holding the neck in an abnormal position.

Causes

Most cases of spasmus nutans begin between age 6 months and 1 year. It usually lasts about 2 years but can go on as long as 5 years.

The cause is unknown, although it may be associated with other medical conditions. A link with iron or vitamin D deficiency has been suggested. In very rare cases, symptoms similar to spasmus nutans may be due to certain types of brain tumors or other serious conditions.

Symptoms

Symptoms of spasmus nutans include:

Exams and Tests

Your health care provider will perform a physical exam of your child. You may be asked about your child's symptoms.

Tests may include:

Treatment

Spasmus nutans that isn't related to another medical problem, such as brain tumor, requires no treatment. If the symptoms are caused by another condition, your provider will recommend appropriate treatment.

Outlook (Prognosis)

Usually, this disorder goes away on its own within 1 to 2 years without treatment. Some children have residual eye symptoms that need follow-up care.

When to Contact a Medical Professional

Contact your child's provider if your child has rapid, movements of the eyes, or head nodding. Your provider will need to perform an exam to check for other possible causes for the symptoms.

References

Hertle RW, Hanna NN. Supranuclear eye movement disorders, acquired and neurologic nystagmus. In: Lyons CJ, Lambert SR, eds. Taylor and Hoyt's Pediatric Ophthalmology and Strabismus. 6th ed. Philadelphia, PA: Elsevier; 2023:chap 91.

Mikati MA, Obeld MM. Conditions that mimic seizures. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 634.

Rucker JC, Lavin PJM. Neuro-ophthalmology: ocular motor system. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley's and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 18.



Review Date: 4/16/2025
Reviewed By: Joseph V. Campellone, MD, Department of Neurology, Cooper Medical School at Rowan University, Camden, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

© 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.
© 1997- adam.comAll rights reserved.
A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.